PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-06-19

Date Title Company
19-Jun-2020 Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata Reistone Biopharma